ZK824190
ZK824190 is an orally available and selective urokinase plasminogen activator (uPA) inhibitor as a potential treatment for multiple sclerosis. IC50s of 237, 1600 and 1850 nM for uPA, tPA, and Plasmin, respectively[1].
Product Specifications
CAS Number
2254001-81-3
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
PAI-1; Ser/Thr Protease
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/zk824190.html
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
CC[C@@H](OC1=NC(OC2=CC(C3=CC=CC(CN)=C3)=CC=C2)=C(F)C=C1F)C(O)=O
Molecular Formula
C22H20F2N2O4
Molecular Weight
414.40
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Islam I, et al. Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis. Bioorg Med Chem Lett. 2018 Nov 1;28 (20) :3372-3375.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-P237953-25MG 25 mg
1,2,3,7,8-Pentachlorodibenzo-p-dioxin (>85%)
Sign In for Pricing
View Details 
![CAD Mouse Monoclonal Antibody [Clone ID: OTI10A3]](https://cdn.genprice.uk/products/937/68dd18bb061270361e908de9/imageurl/cf812683.webp)
E-CL-H0465-01 24 Tests
Human BRCA2 (Breast Cancer Susceptibility Protein 2) CLIA Kit
Sign In for Pricing
View Details E-CL-H0465-02 48 Tests
Human BRCA2 (Breast Cancer Susceptibility Protein 2) CLIA Kit
Sign In for Pricing
View Details E-CL-H0465-03 96 Tests
Human BRCA2 (Breast Cancer Susceptibility Protein 2) CLIA Kit
Sign In for Pricing
View Details